
Terapi Controller pada Asma
Author(s) -
Alexander Kam,
Fauzar Fauzar,
Roza Kurniati,
Zulkarnain Arsyad
Publication year - 2021
Publication title -
jurnal ilmu kesehatan indonesia
Language(s) - English
Resource type - Journals
ISSN - 2722-4848
DOI - 10.25077/jikesi.v1i3.467
Subject(s) - medicine , asthma , airway obstruction , intensive care medicine , airway , pharmacodynamics , drug , lung , anesthesia , pharmacology , pharmacokinetics
Asthma, according to the National Heart Lung and Blood Institute (NHBLI) in 2002, is a chronic inflammatory disorder of the airways that involves the role of many cells and cellular components. The long-term goals of asthma management are to achieve good symptom control and maintain normal living activities and to minimize the risk of exacerbations, airway obstruction, and side effects. The drugs available for asthma therapy are divided into long-term control or controller medication and rapid-acting or reliever medication based on their pharmacodynamics and clinical effects. Controller is a therapy given to reduce chronic airway inflammation, control symptoms, and reduce the risk of exacerbations and decreased lung function. There are several asthma controller drug options that have their respective advantages and disadvantages. Selection of the right controller will provide good asthma control.
Keyword: Ashtma, therapy, controller